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Conversion of a non-heme iron-dependent
sulfoxide synthase into a thiol dioxygenase by a
single point mutation†
Kristina V. Goncharenko and Florian P. Seebeck*
EgtB from Mycobacterium thermoresistibile catalyzes O2-dependent
sulfur–carbon bond formation between the side chains of Na-trimethyl
histidine and c-glutamyl cysteine as a central step in ergothioneine
biosynthesis. A single point mutation converts this enzyme into a
c-glutamyl cysteine dioxygenase with an efficiency that rivals
naturally evolved thiol dioxygenases.
Non-heme iron oxygenases catalyze a broad range of chemically
diﬃcult reactions and therefore provide intriguing starting
points to develop novel enzymes for industrial applications.
Despite remarkable progress in mechanistic enzymology,1–7 only
few design studies describing modified non-heme iron enzymes
with engineered activities8–12 have explored this potential for
technological innovation so far. As a further step into this
nascent field of enzyme engineering we present an example of
a monooxygenase that was converted into an efficient thiol
dioxygenase based on minimal active site redesign.13
The sulfoxide synthase (EC 1.14.99.50) EgtB catalyzes the
central step in ergothioneine biosynthesis (1, Fig. 1).14–16 EgtB
mediates carbon–sulfur bond formation between g-glutamyl
cysteine (gGC) and the imidazole ring of Na-trimethylated
histidine (TMH). Concomitant oxidation of the bridging sulfur
atom (2, Fig. 1) makes the overall reaction a four-electron
oxidation, and classifies EgtB as a monooxygenase.17 The active
site of EgtB contains ferrous iron coordinated by a 3-His facial
triad, the thiolate side chain of gGC and the imidazole ring of
TMH (Fig. 2).16 In this structure the likely O2-binding site is
occupied by a water molecule or a hydroxide that also hydrogen
bonds to the side chain of Gln55 (2.8 Å), a neighbouring water
molecule (3.1 Å) and the side chain a Tyr377 (2.8 Å). In this
report we show that substitution of Tyr377 to Phe completely
changes the catalytic activity of EgtB.
The variant enzyme (EgtBY377F) catalyzes dioxygenation of
gGC with an eﬃciency similar to that of naturally evolved
cysteine dioxygenases (CDO, EC 1.13.11.20).18,19 CDOs also
bind ferrous iron by a 3-His facial triad combined with the
thiolate and amine ligands from the substrate (Fig. 2), but
the overall structures of EgtB and CDO are unrelated. A wealth
of structural, biochemical, spectroscopic and computational
investigations suggest that CDO catalysed formation of cysteine
sulfinic acid (3) goes though a cysteine bound iron(III)–superoxo
species (a, Fig. 2), followed by intermediates b and c.18–26 The
structural and functional similarities between the active sites of
CDO and EgtB raise the possibility that thiol dioxygenation and
sulfoxide synthesis may proceed through at least one common
catalytic intermediate.
The following kinetic analysis of EgtBwt and EgtBY377F
indicates that an iron(III)–superoxo species (A, a) may be this
common intermediate.
Fig. 1 Top: EgtBwt catalyzes oxidative C–S bond formation between
g-glutamyl cysteine andNa-trimethyl histidine (TMH) to form 2. This sulfoxide
is the central intermediate in the biosynthesis of ergothioneine (1). EgtBY377F
catalyzes the formation of gGC dioxide (4) mimicking naturally evolved
cysteine dioxygenases (CDO) which produce cysteine sulfinic acid (3).
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To conduct this study we produced EgtBwt and EgtBY377F in
Escherichia coli, and we monitored the rate of enzyme catalyzed
sulfoxide (2) production using a published HPLC-based assay.16
Michaelis–Menten analysis of this data revealed 103-fold less
sulfoxide synthase activity for EgtBY377F than for EgtBwt. This
reduction is entirely due to a smaller kcat, since KM,TMH remained
unchanged (Table 1, Fig. S1 and S2, ESI†). We also determined
the substrate kinetic isotope effect (KIE) using C2-deuterated
TMH. Because both enzymes showed a substrate KIE near unity
(Fig. S3, ESI†) we concluded that C2–H bond cleavage is not rate
limiting in either enzyme and that hydrogen or proton removal
from TMH is not an essential function of Tyr377.
When we compared the rates of gGC consumption and sulfoxide
production (Fig. S4, ESI†) we found a rather surprising diﬀerence
between the two enzymes. In EgtBwt catalyzed reactions substrate
consumption (kgGC,wt = 0.4  0.02 s1) and sulfoxide formation
(ksulfoxide,wt = 0.3 0.06 s1) were essentially coupled. By contrast, in
EgtBY377F catalysed reactions, gGC consumption was much faster
(kgGC,Y377F = 0.6 0.1 s1) than sulfoxide production (ksulfoxide,Y377F =
0.002 s1). NMR analysis of the completed reactions revealed that
EgtBY377F oxidizes most substrate to gGC dioxide (4) instead (Fig. S5
and S6, ESI†). This new activity still depends on TMH, which
indicates that dioxygenation proceeds via the same substrate
complex as sulfoxide production. In the absence of TMH both
EgtBwt and EgtBY377F catalyzed gGC dioxygenation at a similarly
slow rate (kgGC = 0.008 s
1, Fig. S7 and S8, ESI†). Apparently, the
single substrate complex is significantly less reactive and its
reaction specificity is not influenced by residue 377.
We also determined the Michaelis–Menten parameters for
EgtBY377F catalyzed gGC dioxygenation (Table 1). Considering that
Fig. 2 Top: Active site of EgtB from M. thermoresistibile in complex with Mn(II) (magenta sphere), TMH and gGC (PDB code 4X8D).16 One plausible
catalytic mechanism has been proposed for EgtBwt: the substrate bound complex reacts with O2 to form an iron(III)–superoxo species (A). Protonation by
Tyr377 and reduction by one-electron transfer from gGC leads to the iron(III)–hydroperoxo species (B). C–S bond formation between the gGC radical and
TMH (C), deprotonation by Tyr377 and stereospecific sulfoxidation of D to the S-sulfoxide 2 concludes the catalytic cycle. Gray: in the absence of an
acidic residue at position 377 species A predominantly reacts to B0 which reacts further to gGC dioxide (4) potentially through a CDO-like mechanism.
Bottom: Active site of murine CDO in complex with cysteine (PDB code 4IEW).27 The consensus mechanism of CDO proceeds via a cysteine bond
iron(III)–superoxo species (a), followed by irreversible S–O bond formation (b), homolytic O–O bond scission (c), and radical rebound to form cysteine
sulfinic acid (3).18–26
Table 1 Kinetic parameters of EgtB variantsa
pH kcat,gGC (s
1) KM,gGC (mM) kcat/KM (M
1 s1) kcat,TMH (s
1) KM,TMH (mM) kcat/KM (M
1 s1)
Sulfoxide synthase
EgtBwt 8.0 7.5  101 27 2.8  104 8.5  101 10 7.4  104
EgtBY377F 8.0 — — — 0.9  104 10 8.5  101
EgtBwt 6.0 1.1 370 2.0  103 1.2  100 22 5.7  104
EgtBY377F 6.0 — — — 3.2  103 40 8.0  101
gGC dioxygenase
EgtBY377F 8.0 1.2 110 1.1  104 — — —
EgtBY377F 6.0 0.9 320 2.7  103 — — —
CDOmurine
19 7.5 1.8 700 2.6  104 — — —
a Standard deviation correspond to less than 20% of averaged value. Apparent kcat and kcat/KM in the presence co-substrate in a concentration at
least 3-fold higher than the corresponding KM.
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this protein may never have evolved to catalyze this alternative
reaction it is particularly striking that its catalytic efficiency
closely matches that of naturally evolved CDOs (Table 1).
The kinetic parameters for EgtBY377F catalyzed dioxygena-
tion are also remarkably similar to those for EgtBwt catalyzed
sulfoxide synthesis (Table 1). Given the similar apparent KM in
both enzymes for both substrates we have no indication that the
substitution of residue 377 aﬀected binding of TMH or gGC. The
fact that both enzymes oxidize gGC at similar rates further suggest
that the eﬃciency of O2 binding and activation have not changed
either. However, the resulting ternary complex (A, Fig. 2) does
behave quite diﬀerently in the wild-type and variant protein.
In the presence of ascorbate EgtBwt and EgtBY377F catalyze
many hundreds of turnovers, without any sign of inactivation.
Without ascorbate EgtBwt oxidizes to the inactive iron(III)
form after approximately 100 turnovers,16 corresponding to
an autoxidation rate of kautoxidation = 0.01 s
1 (Fig. S9, ESI†).
This inactivation is reversible by addition of ascorbate,28,29 and
is best explained by unproductive decay of the iron(III)–superoxo
species A to superoxide and ferric EgtB.30–33 EgtBY377F inactivates
10-fold faster (kautoxidation = 0.1 s
1, Fig. S10, ESI†), indicating
that the initial iron coordinated oxygen species may be destabi-
lized by the Tyr377 to Phe substitution (Fig. 2).
This substitution also influences the solvent KIE on EgtB. The
sulfoxide synthase activity of EgtBwt and the gGC dioxygenase
activity of EgtBY377F are both characterized by a solvent KIE near
unity (1.2  0.2 and 0.9 0.1, Fig. S11 and S12, ESI†). In contrast,
the sulfoxide synthase activity of EgtBY377F exhibited a solvent KIE
of 1.9  0.1 (Fig. S11, ESI†), indicating that one or multiple
protons or hydrogen atoms are being transferred in the rate
limiting step. Because the dioxygenase activity is not aﬀected
by solvent deuteration we conclude that this transfer occurs
exclusively on sulfoxide synthase pathway. In the context of the
proposed mechanisms for EgtB and CDO (Fig. 2) the most likely
candidate for this solvent isotope sensitive step would be proto-
nation of the iron(III)–superoxo intermediate A. Protonation of this
oxygen species may be important to increase the thiyl radical
character of the gGC ligand (B), which in turn could attack the
imidazole ring of TMH (C). In EgtBY377F the iron coordinated
superoxide is not protonated an may instead attack the electron
deficient sulfur atom on gGC (A to B0). The analogous S–O bond
forming step (a to b) has been found as the first irreversible step
in CDO catalyzed cysteine dioxygenation (Fig. 2).18–26
According to this model, species A can either react via
irreversible proton transfer to intermediate B, or via irreversible
S–O bond formation leading to intermediate B0 simply depend-
ing on the availability of an acidic proton in the active site. We
did indeed observe a 3.5-fold increase in kcat for EgtBY377F
catalyzed sulfoxide synthesis when the reaction pH was lowered
from 8.0 to 6.0 (Table 1). The observed sulfoxide synthase
activity is a hyperbolic function of proton concentration with
a half-saturation point (KM,proton) near pH 7 (Fig. S13, ESI†).
This dependence is consistent with a general acid mechanism in
which the phosphate buffer (pKa,monoanion = 7.2), or an alter-
native protein residue with a similar pKa can replace Tyr377 as
an indirect proton source. The kcat of gGC dioxygenase activity of
the same protein proved nearly constant in the same pH range
(Table 1) which is in agreement with the proposition that acid
catalysis is less important in the first irreversible step of thiol
dioxygenation (A to B0 or a to b0).
In conclusion, we identified Tyr377 as a catalytic residue in
EgtB from M. thermoresistibile. Mutation of this residue to Phe
did not measurably aﬀect substrate binding or O2 activation,
but instead changed the dominant activity of this enzyme. The
remaining sulfoxide synthase activity of EgtBY377F is character-
ized by an increased solvent KIE and significant dependence
on buﬀer pH. These observations are best explained with a
mechanistic model suggesting that (i) the sulfoxide synthase
and the thiol dioxygenase reaction pathways share a common
intermediate, (ii) that this intermediate is the iron(III)–superoxo
species A, and (iii) that protonation by Tyr377 is essential to
move this species towards sulfoxide synthesis, and away from
gGC dioxygenation. This report the first example of a non-heme
iron enzyme which could be engineered to efficiently catalyze a
completely different reaction type than the parent enzyme.
CDOs and EgtB belong to entirely unrelated protein families
and evolved along diﬀerent selective pressures. The fact that
EgtBY377F catalyzes thiol dioxygenation with similar eﬃciency as
CDOs makes the two enzymes a stunning example of accidental
convergent evolution. We anticipate that detailed comparison of
the two catalyst will prove a fruitful avenue to advance our
current understanding of both reaction types.18–26
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